Weight Lose: Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed

Saturday, May 9, 2020

Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed

Patients who took a common heartburn medicine while hospitalized for Covid-19 were more than twice as likely to survive the infection, according to a paper posted Friday on a pre-publication website. But it's unclear whether the patients fared better because of the famotidine or if it was a coincidence.